Clinical Trial Update: Efficacy, Safety and Immunogenicity of Enerceptan Compared to Enbrel in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Enerceptan with Enbrel in rheumatoid arthritis reports on efficacy, safety and immunogenicity; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• Enerceptan

Snippet

Sponsor: Gema Biotech S.A. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED